Study on cancer risk assessment method using 5-aminolevulinic acid - cancer risk assessment method using 5-aminolevulinic acid

Teikyo University School of medicine0 个研究点目标入组 400 人开始时间: 2020年1月29日最近更新: 2024年5月27日

试验速览

暂无简介。

•1) Patients with a history or diagnosis of porphyria 2) Pregnant women or patients who may become pregnant or breastfeeding 3) Patients who have difficulty in filling in the consent form or have problems with the urine collection procedure due to psychiatric complications, etc. 4) Patients with primary tumors other than the target 4 carcinomas 5) Patients who underwent high-concentration vitamin C therapy or treatment with 5-ALA, such as heat, radiation, or other phototherapy, one month before urine collection 6) Patients with severe cardiovascular disease, lung, liver, or kidney disease who are undergoing treatment or are at risk for it 7) Patients who are required to prescribe drugs separately prescribed on the day of urine collection 8) Other patients who are judged inappropriate by the doctor's judgment

发起方

Teikyo University School of medicine